Andrew Hough v. HHS - Influenza, Guillain-Barre Syndrome (GBS) (2018)
Case summary [AI summaries can sometimes make mistakes]
Andrew Hough filed a petition for compensation under the National Vaccine Injury Compensation Program on September 21, 2016, alleging that he suffered Guillain-Barre Syndrome (GBS) caused by his November 4, 2014 influenza vaccination. He further alleged that he suffered residual effects for more than six months and that there had been no prior award or settlement for his condition.
The respondent denied that the flu vaccine caused his GBS or any other injury. Despite the respondent's denial, the parties filed a joint stipulation on June 28, 2017, agreeing that compensation should be awarded.
Chief Special Master Nora Beth Dorsey found the stipulation reasonable and adopted it as the decision of the Court. Andrew Hough was awarded a lump sum of $190,000.00 as compensation for all items of damages.
The public decision does not describe the specific onset of symptoms, medical tests, treatments, or expert witnesses. Petitioner was represented by Lawrence R.
Cohan of Anapol Weiss, and respondent was represented by Glenn Alexander MacLeod of the U.S. Department of Justice.
Theory of causation
Petitioner Andrew Hough alleged that his November 4, 2014 influenza vaccination caused Guillain-Barre Syndrome (GBS), with residual effects lasting more than six months. Respondent denied causation. The parties filed a joint stipulation for compensation, which was adopted by Chief Special Master Nora Beth Dorsey. The stipulation resulted in a lump sum award of $190,000.00 for all items of damages. The specific theory of causation, medical evidence, expert testimony, and mechanism of injury are not detailed in the provided public decision text. Petitioner counsel was Lawrence R. Cohan, and respondent counsel was Glenn Alexander MacLeod. The decision date was April 5, 2018, based on a stipulation filed June 28, 2017.
Source PDFs
USCOURTS-cofc-1_16-vv-01175